Ad is loading...
HSCS
Price
$4.47
Change
+$1.05 (+30.70%)
Updated
Dec 5, 04:59 PM (EDT)
RSLS
Price
$4.90
Change
-$0.59 (-10.75%)
Updated
Dec 5, 04:59 PM (EDT)
Ad is loading...

HSCS vs RSLS

Header iconHSCS vs RSLS Comparison
Open Charts HSCS vs RSLSBanner chart's image
HeartSciences
Price$4.47
Change+$1.05 (+30.70%)
Volume$554
CapitalizationN/A
ReShape Lifesciences
Price$4.90
Change-$0.59 (-10.75%)
Volume$1.77K
CapitalizationN/A
HSCS vs RSLS Comparison Chart
Loading...
HSCS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
HSCS vs. RSLS commentary
Dec 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSCS is a Buy and RSLS is a StrongBuy.

COMPARISON
Comparison
Dec 06, 2024
Stock price -- (HSCS: $3.42 vs. RSLS: $5.49)
Brand notoriety: HSCS and RSLS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HSCS: 70% vs. RSLS: 17%
Market capitalization -- HSCS: $7.66M vs. RSLS: $4.33M
HSCS [@Medical Specialties] is valued at $7.66M. RSLS’s [@Medical Specialties] market capitalization is $4.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSCS’s FA Score shows that 1 FA rating(s) are green whileRSLS’s FA Score has 0 green FA rating(s).

  • HSCS’s FA Score: 1 green, 4 red.
  • RSLS’s FA Score: 0 green, 5 red.
According to our system of comparison, HSCS is a better buy in the long-term than RSLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSCS’s TA Score shows that 4 TA indicator(s) are bullish while RSLS’s TA Score has 4 bullish TA indicator(s).

  • HSCS’s TA Score: 4 bullish, 5 bearish.
  • RSLS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RSLS is a better buy in the short-term than HSCS.

Price Growth

HSCS (@Medical Specialties) experienced а +17.93% price change this week, while RSLS (@Medical Specialties) price change was -4.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.96%. For the same industry, the average monthly price growth was +0.40%, and the average quarterly price growth was -0.92%.

Reported Earning Dates

HSCS is expected to report earnings on Sep 12, 2024.

RSLS is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Medical Specialties (-0.96% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HSCS($7.66M) has a higher market cap than RSLS($4.33M). RSLS YTD gains are higher at: -62.092 vs. HSCS (-80.000). HSCS has higher annual earnings (EBITDA): -6M vs. RSLS (-36.72M). HSCS has more cash in the bank: 7.08M vs. RSLS (1.45M). RSLS has less debt than HSCS: RSLS (285K) vs HSCS (1.06M). RSLS has higher revenues than HSCS: RSLS (9.81M) vs HSCS (18.6K).
HSCSRSLSHSCS / RSLS
Capitalization7.66M4.33M177%
EBITDA-6M-36.72M16%
Gain YTD-80.000-62.092129%
P/E RatioN/AN/A-
Revenue18.6K9.81M0%
Total Cash7.08M1.45M488%
Total Debt1.06M285K372%
FUNDAMENTALS RATINGS
RSLS: Fundamental Ratings
RSLS
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HSCSRSLS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
HSCS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNDY292.8012.00
+4.27%
monday.com Ltd
TCRT2.42N/A
N/A
Alaunos Therapeutics Inc.
CABO409.31-1.36
-0.33%
Cable One
SPWH2.19-0.01
-0.45%
Sportsman's Warehouse Holdings
LNZA1.04-0.05
-4.59%
LanzaTech Global

HSCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, HSCS has been loosely correlated with GENE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HSCS jumps, then GENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSCS
1D Price
Change %
HSCS100%
+3.32%
GENE - HSCS
46%
Loosely correlated
N/A
RSLS - HSCS
35%
Loosely correlated
-1.61%
BIAF - HSCS
32%
Poorly correlated
-4.55%
HSDT - HSCS
32%
Poorly correlated
-7.42%
PSNL - HSCS
22%
Poorly correlated
+2.57%
More

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with GENE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then GENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
-1.61%
GENE - RSLS
45%
Loosely correlated
N/A
HSCS - RSLS
35%
Loosely correlated
+3.32%
GMED - RSLS
31%
Poorly correlated
-0.81%
NARI - RSLS
30%
Poorly correlated
+1.26%
AZTA - RSLS
30%
Poorly correlated
-0.09%
More